Thatcher, N <br/><br/>
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer.  [electronic resource] 

 -  British journal of cancer  May 1999 
 - 396-402 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6690369  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anemia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Small Cell--blood<br/>Cisplatin--administration & dosage<br/>Epoetin Alfa<br/>Erythrocyte Transfusion<br/>Erythropoietin--adverse effects<br/>Female<br/>Hematinics--adverse effects<br/>Hemoglobins--metabolism<br/>Humans<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Quality of Life<br/>Recombinant Proteins